Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › dutasteride

dutasteride

4 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of dutasteride

16 trials tracked of dutasteride: 9 in phase 3 or 4 and 1 with published results. The most-cited published study has 4 citations.

16Trials tracked
9Phase 3 & 4
0Recruiting
1With published results
Phase distribution
Phase 4 5 Phase 3 4 Phase 2 5 Other / NA 2
  1. Phase 4 Dutasteride Treatment for the Reduction of Heavy Drinking in Men Completed · 4 cited
  2. Phase 4 Dutasteride for the Reduction of Alcohol Use in Male Drinkers Completed
  3. Phase 4 TRADE-Testosterone Replacement and Dutasteride Effectiveness Completed
  4. Phase 4 Prostate Cancer Study In Men Who Have Failed First-Line Androgen Deprivation Therapy Completed
  5. Phase 4 Assessment Of Dutasteride (AVODART) In Extending The Time To Progression Of Low-Risk, Localized Prostate Cancer In Men Completed
  6. Phase 3 Sexual Function in Men Receiving Dutasteride for Androgenetic Alopecia Completed
Show 10 more trials
  1. Phase 3 "REDUCE" - A Clinical Research Study To Reduce The Incidence Of Prostate Cancer In Men Who Are At Increased Risk Completed
  2. Phase 3 PROS-1-Male Hormonal Contraceptive Regimens on Prostate Tissue Completed
  3. Phase 3 Dutasteride (GI198745) In Benign Prostatic Hyperplasia Subjects Completed
  4. Phase 2 ITT4 Intratesticular Hormonal Milieu in Man (ITT4) Completed
  5. Phase 2 Dutasteride to Treat Spinal and Bulbar Muscular Atrophy (SBMA) Completed
  6. Phase 2 Abiraterone Acetate Combined With Dutasteride for Metastatic Castrate Resistant Prostate Cancer Completed
  7. Phase 2 Study of Enzalutamide (Formerly MDV3100) as a Neoadjuvant Therapy for Patients Undergoing Prostatectomy for Localized Prostate Cancer Completed
  8. Phase 2 Effect of Dutasteride on Androgen-Response Gene Expression in Patients With Advanced Prostate Cancer Completed
  9. N/A MRI and Magnetic Resonance Spectroscopy Imaging in Patients Receiving Dutasteride for Benign Prostatic Hypertrophy and Low-Risk Prostate Cancer Completed
  10. N/A AVODART(Dutasteride) Post-marketing Surveillance(PMS) Completed

Showing the 16 most-cited and recently-updated of 16 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
5-alpha-reductase inhibitors show no statistically significant association with suicide or neuropsychiatric events in BPH or AGA
Urology Meta-analysis
5-alpha-reductase inhibitors show no statistically significant association with suicide or neuropsychiatric events in BPH or AGA Trial shows 5-alpha-reductase inhibitors do not increase suicide risk
This meta-analysis of observational studies examined the risk of suicide and neuropsychiatric events in patients with benign prostatic hyper…
New data suggests that 5-alpha-reductase inhibitors for hair loss or prostate issues are not linked to higher rates of suicide or depression…
Frontiers Oct 5, 2026
5-alpha-reductase inhibitors are associated with increased sexual adverse events in androgenetic alopecia patients
Oncology Meta-analysis
5-alpha-reductase inhibitors are associated with increased sexual adverse events in androgenetic alopecia patients Hair loss medications may cause some side effects for men
This systematic review of 41 studies evaluates the impact of finasteride and dutasteride on sexual dysfunction in patients with hair loss. T…
Men using finasteride or dutasteride for hair loss may experience sexual side effects, though most cases are mild and reversible when the dr…
Frontiers Jun 29, 2026
In an RCT, dutasteride significantly reduced total International Prostate Symptom Score in men with lower urinary tract symptoms over 24 months
Urology RCT
In an RCT, dutasteride significantly reduced total International Prostate Symptom Score in men with lower urinary tract symptoms over 24 months Dutasteride Helps Bladder Flow, But Nighttime Relief Takes Years
This randomized controlled trial enrolled 8122 men with lower urinary tract symptoms and compared dutasteride to placebo over a 24.0-month f…
This common prostate medication works well for flow, but full bladder comfort comes slowly and may not be noticeable.
Apr 21, 2026
Dutasteride-Tadalafil FDC Shows Superior Symptom Reduction in BPH Phase III Trial
Urology RCT
Dutasteride-Tadalafil FDC Shows Superior Symptom Reduction in BPH Phase III Trial Does taking two prostate drugs together work better than just one for symptom relief?
A phase III randomized trial in 619 BPH patients found a fixed-dose combination (FDC) of dutasteride 0.5 mg/tadalafil 5 mg significantly imp…
Men taking two prostate drugs together saw symptom relief twice as fast as single-drug therapy, though they faced more side effects.
Apr 6, 2026